van der Heijden, Thomas
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. [electronic resource]
- Arteriosclerosis, thrombosis, and vascular biology 08 2017
- 1457-1461 p. digital
Publication Type: Journal Article
ISSN: 1524-4636
Standard No.: 10.1161/ATVBAHA.117.309575 doi
Subjects--Topical Terms: Animals Anti-Inflammatory Agents--pharmacology Apolipoproteins E--deficiency Atherosclerosis--genetics Carotid Arteries--drug effects Carotid Artery Diseases--genetics Cells, Cultured Cholesterol--pharmacology Crystallization Dendritic Cells--drug effects Diet, Western Disease Models, Animal Female Furans Genetic Predisposition to Disease Heterocyclic Compounds, 4 or More Rings--pharmacology Indenes Inflammasomes--antagonists & inhibitors Intercellular Adhesion Molecule-1--genetics Interleukin-1beta--metabolism Lipopolysaccharides--pharmacology Macrophages--drug effects Mice, Inbred C57BL Mice, Knockout NLR Family, Pyrin Domain-Containing 3 Protein--antagonists & inhibitors Necrosis Phenotype Plaque, Atherosclerotic RNA, Messenger--genetics Signal Transduction--drug effects Sulfonamides Sulfones--pharmacology Time Factors Vascular Cell Adhesion Molecule-1--genetics